Meanwhile, FUNDC1 expression was significantly higher in BLCA (bladder urothelial carcinoma), BRCA (breast invasive carcinoma), CHOL (cholangiocarcinoma), COAD (colon adenocarcinoma), HNSC-HPV positive (head and neck squamous carcinoma-HPV positive), KICH (kidney chromophobe), LIHC (liver hepatocellular carcinoma), LUAD (lung adenocarcinoma), LUSC (lung squamous cell carcinoma), PRAD (prostate adenocarcinoma), and UCEC (uterine corpus endometrial carcinoma) than in their respective adjacent normal tissues. Here, FUNDC1 is linked to prostate adenocarcinoma.